UK Biobank is a large long-term biobank study in the United Kingdom (UK) which is investigating the respective contributions of genetic predisposition and environmental exposure (including nutrition, lifestyle, medications etc.) to the development of disease. It began in 2007.
The study is following about 500,000 volunteers in the UK, enrolled at ages from 40 to 69.
Initial enrollment took place over four years from 2006, and the volunteers will be followed for at least 25 years thereafter.
Prospective participants were invited to visit an assessment centre,
at which they completed an automated questionnaire and were interviewed about lifestyle, medical history and nutritional habits; basic variables such weight, height, blood pressure etc. were measured; and blood and urine samples were taken. These samples have been preserved so that it is possible to later extract DNA and measure other biologically important substances. During the whole duration of the study it is intended that all disease events, drug prescriptions and deaths of the participants are recorded in a database, taking advantage of the centralized UK National Health Service.
An animation covering the background of UK Biobank
published: 17 Jul 2020
Overview - UK Biobank Research Analysis Platform
This video provides a short overview of the UK Biobank Research Analysis Platform and its core features.
published: 22 Feb 2021
UK Biobank Data: About the Data & How to Apply for Access
Learn about the mission of the UK Biobank, the new 300k whole exome sequencing data release and how to become an approved researcher.
Topics included:
-Who is the UK Biobank?
-What data is available to researchers?
-Recently released data: 300K WES
-Other types of data: imaging, COVID, healthcare records
-Data roadmap
-The process for applying to become an approved researcher and submitting a research proposal
-Tips on speeding up your application and approvals
-Accessing the data on the Research Analysis platform
00:00 Introduction
01:25 Overview of UK Biobank and the Data
15:03 300k Whole Exome Data: Overview and Best Practices
25:29 Access and How to Apply to Use the Resource
38:35 Getting on to RAP
46:43 Final Q&A
published: 12 Oct 2021
Introducing the UK Biobank Research Analysis Platform
Leveraging the power and scalability of the cutting-edge, cloud-native DNAnexus Platform, the Research Analysis Platform enables researchers easily and quickly to explore and analyze the incredibly rich UK Biobank dataset.
published: 23 Sep 2021
UK Biobank Scientific Conference 2021: Multi-omics in UK Biobank
published: 26 Feb 2021
How imaging data enables scientific discoveries: UK Biobank participant event
This event took place online for UK Biobank participants on 21st March 2022.
Learn about the mission of the UK Biobank, the new 300k whole exome sequencing data release and how to become an approved researcher.
Topics included:
-Who is ...
Learn about the mission of the UK Biobank, the new 300k whole exome sequencing data release and how to become an approved researcher.
Topics included:
-Who is the UK Biobank?
-What data is available to researchers?
-Recently released data: 300K WES
-Other types of data: imaging, COVID, healthcare records
-Data roadmap
-The process for applying to become an approved researcher and submitting a research proposal
-Tips on speeding up your application and approvals
-Accessing the data on the Research Analysis platform
00:00 Introduction
01:25 Overview of UK Biobank and the Data
15:03 300k Whole Exome Data: Overview and Best Practices
25:29 Access and How to Apply to Use the Resource
38:35 Getting on to RAP
46:43 Final Q&A
Learn about the mission of the UK Biobank, the new 300k whole exome sequencing data release and how to become an approved researcher.
Topics included:
-Who is the UK Biobank?
-What data is available to researchers?
-Recently released data: 300K WES
-Other types of data: imaging, COVID, healthcare records
-Data roadmap
-The process for applying to become an approved researcher and submitting a research proposal
-Tips on speeding up your application and approvals
-Accessing the data on the Research Analysis platform
00:00 Introduction
01:25 Overview of UK Biobank and the Data
15:03 300k Whole Exome Data: Overview and Best Practices
25:29 Access and How to Apply to Use the Resource
38:35 Getting on to RAP
46:43 Final Q&A
Leveraging the power and scalability of the cutting-edge, cloud-native DNAnexus Platform, the Research Analysis Platform enables researchers easily and quickly ...
Leveraging the power and scalability of the cutting-edge, cloud-native DNAnexus Platform, the Research Analysis Platform enables researchers easily and quickly to explore and analyze the incredibly rich UK Biobank dataset.
Leveraging the power and scalability of the cutting-edge, cloud-native DNAnexus Platform, the Research Analysis Platform enables researchers easily and quickly to explore and analyze the incredibly rich UK Biobank dataset.
Learn about the mission of the UK Biobank, the new 300k whole exome sequencing data release and how to become an approved researcher.
Topics included:
-Who is the UK Biobank?
-What data is available to researchers?
-Recently released data: 300K WES
-Other types of data: imaging, COVID, healthcare records
-Data roadmap
-The process for applying to become an approved researcher and submitting a research proposal
-Tips on speeding up your application and approvals
-Accessing the data on the Research Analysis platform
00:00 Introduction
01:25 Overview of UK Biobank and the Data
15:03 300k Whole Exome Data: Overview and Best Practices
25:29 Access and How to Apply to Use the Resource
38:35 Getting on to RAP
46:43 Final Q&A
Leveraging the power and scalability of the cutting-edge, cloud-native DNAnexus Platform, the Research Analysis Platform enables researchers easily and quickly to explore and analyze the incredibly rich UK Biobank dataset.
UK Biobank is a large long-term biobank study in the United Kingdom (UK) which is investigating the respective contributions of genetic predisposition and environmental exposure (including nutrition, lifestyle, medications etc.) to the development of disease. It began in 2007.
The study is following about 500,000 volunteers in the UK, enrolled at ages from 40 to 69.
Initial enrollment took place over four years from 2006, and the volunteers will be followed for at least 25 years thereafter.
Prospective participants were invited to visit an assessment centre,
at which they completed an automated questionnaire and were interviewed about lifestyle, medical history and nutritional habits; basic variables such weight, height, blood pressure etc. were measured; and blood and urine samples were taken. These samples have been preserved so that it is possible to later extract DNA and measure other biologically important substances. During the whole duration of the study it is intended that all disease events, drug prescriptions and deaths of the participants are recorded in a database, taking advantage of the centralized UK National Health Service.
They analyzed a subset of UK Biobank participants, comparing individuals with no major medical or mental health conditions to those diagnosed with schizophrenia, bipolar disorder, depression, and generalized anxiety disorder.
The study, published in the American Journal of Clinical Nutrition, examined data obtained from the UK Biobank, involving over 200,000 participants aged 40 to 69 years ... The result was remarkable ... Say ‘NO’ to sugar ... LifestyleNews .
There’s an undeniable link between dietary choices and neurodegenerative diseases like Alzheimer’s... ALSO READ ... The study examined data obtained from the UK Biobank, involving over 200,000 participants aged 40 to 69 years ... The result was remarkable ... ....
However, these benefits were not observed for people who had their coffee sweetened by sugar or artificial sweeteners.The study analysed data of 204,847 UK Biobank participants, aged 40-69 out of which 55% were female ... 24% weren't coffee drinkers.
The researchers analyzed data from the UK Biobank, a large-scale biomedical database containing health, genetic, and lifestyle information from approximately 500,000 individuals living in the United Kingdom.
Your browser does not support iframes ... In the UK, 44,000 Brits are diagnosed each year, and there are roughly 16,800 deaths.Read More. EXCLUSIVE ... The researchers looked at 458,543 adults ages 40 to 69 from the database UK Biobank ... The researchers wrote ... .
... branching angle and complexity of the veins and arteries.In the Heart study, researchers looked at the health data of 45,161 people aged above 55, collected as part of the UK biobank study.
The researchers looked at data from 172,315 members of the UK Biobank, all of whom were free from cardiometabolic (CM) diseases ― like type two diabetes, stroke, and heart attack ― at the start of the study.
About one million people are living with some form of dementia in the UK ... The study was based on data taken from the UK Biobank, which performs ongoing research on 500,000 adults across the country.
About one million people are living with some form of dementia in the UK ... The study was based on data taken from the UK Biobank, which performs ongoing research on 500,000 adults across the country.
Scientists are set to start investigating the proteins of half a million volunteers from the massive UK Biobank health study, which follows people from middle-age to old age ... of UK Biobank, said.
UKB-PPP is a collaboration between UK Biobank and 14 leading biopharmaceutical companies, with the goal to make available important information on the human proteome to UK Biobank-approved researchers across the world.